Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Change in Taxes (2020 - 2023)

Oncology Institute (TOI) has disclosed Change in Taxes for 4 consecutive years, with -$255000.0 as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Change in Taxes fell 93.18% year-over-year to -$255000.0, compared with a TTM value of -$133000.0 through Dec 2023, down 208.13%, and an annual FY2023 reading of -$255000.0, down 307.32% over the prior year.
  • Change in Taxes was -$255000.0 for Q4 2023 at Oncology Institute, down from -$1000.0 in the prior quarter.
  • Across five years, Change in Taxes topped out at $4.4 million in Q3 2021 and bottomed at -$6.0 million in Q4 2021.
  • Average Change in Taxes over 4 years is -$40833.3, with a median of $50025.0 recorded in 2020.
  • Peak annual rise in Change in Taxes hit 8662.0% in 2021, while the deepest fall reached 1291.81% in 2021.
  • Year by year, Change in Taxes stood at $505700.0 in 2020, then crashed by 1291.81% to -$6.0 million in 2021, then skyrocketed by 97.81% to -$132000.0 in 2022, then tumbled by 93.18% to -$255000.0 in 2023.
  • Business Quant data shows Change in Taxes for TOI at -$255000.0 in Q4 2023, -$1000.0 in Q3 2023, and -$132000.0 in Q4 2022.